venBio Select Advisor

Avoro Capital Advisors as of March 31, 2024

Portfolio Holdings for Avoro Capital Advisors

Avoro Capital Advisors holds 46 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
United Therapeutics Corp Common (UTHR) 7.7 $657M 2.9M 229.72
Apellis Pharmaceuticals Common (APLS) 7.6 $653M 11M 58.78
Ascendis Pharma Sponsored ADR (ASND) 7.0 $600M 4.0M 151.17
Sarepta Therapeutics Common (SRPT) 6.6 $562M 4.3M 129.46
Madrigal Pharmaceuticals Common (MDGL) 6.1 $519M 1.9M 267.04
Argenx Se Sponsored ADR (ARGX) 5.7 $488M 1.2M 393.72
Krystal Biotech Common (KRYS) 5.3 $455M 2.6M 177.93
Spdr Series Trust - S&p Biotech Etf (XBI) 4.8 $408M 4.3M 94.89
Biomarin Pharmaceutical Common (BMRN) 4.4 $381M 4.4M 87.34
Amicus Therapeutics Common (FOLD) 3.8 $323M 27M 11.78
Cerevel Therapeutics Hldng Common (CERE) 3.7 $319M 7.6M 42.27
Viking Therapeutics Common (VKTX) 3.4 $294M 3.6M 82.00
Arrowhead Pharmaceuticals Common (ARWR) 2.9 $245M 8.6M 28.60
Xenon Pharmaceuticals Common (XENE) 2.8 $244M 5.7M 43.05
Alpine Immune Sciences Common 2.7 $229M 5.8M 39.64
Vera Therapeutics Common (VERA) 2.6 $227M 5.3M 43.12
Iovance Biotherapeutics Common (IOVA) 2.0 $173M 12M 14.82
Intra-cellular Therapies Common (ITCI) 2.0 $171M 2.5M 69.20
Kymera Therapeutics Common (KYMR) 1.8 $156M 3.9M 40.20
Avidity Biosciences Common (RNA) 1.7 $149M 5.8M 25.52
Moonlake Immunotherapeutics Class A Ord (MLTX) 1.5 $130M 2.6M 50.23
Syndax Pharmaceuticals Common (SNDX) 1.2 $101M 4.2M 23.80
Macrogenics Common (MGNX) 1.1 $91M 6.2M 14.72
Kura Oncology Common (KURA) 1.0 $82M 3.9M 21.33
Autolus Therapeutics Sponsored ADR (AUTL) 0.9 $79M 12M 6.38
Spyre Therapeutics Common (SYRE) 0.8 $70M 1.8M 37.93
Soleno Therapeutics Common (SLNO) 0.8 $70M 1.6M 42.80
Biocryst Pharmaceuticals Common (BCRX) 0.8 $66M 13M 5.08
Ocular Therapeutix Common (OCUL) 0.8 $65M 7.1M 9.10
Taysha Gene Therapies Common (TSHA) 0.6 $54M 19M 2.87
Tourmaline Bio Common (TRML) 0.6 $51M 2.2M 22.90
Roivant Sciences Common (ROIV) 0.6 $49M 4.7M 10.54
Alnylam Pharmaceuticals Common (ALNY) 0.5 $45M 300k 149.45
Mannkind Corp Common (MNKD) 0.5 $41M 9.0M 4.53
Merus N V Common (MRUS) 0.5 $40M 889k 45.03
Vaxcyte Common (PCVX) 0.5 $39M 575k 68.31
Ultragenyx Pharmaceutical Common (RARE) 0.5 $39M 830k 46.69
Marinus Pharmaceuticals Common (MRNS) 0.4 $37M 4.1M 9.04
Rocket Pharmaceuticals Common (RCKT) 0.4 $34M 1.3M 26.94
Monte Rosa Therapeutics Common (GLUE) 0.4 $32M 4.5M 7.05
Cg Oncology Common (CGON) 0.4 $31M 700k 43.90
Crispr Therapeutics Common (CRSP) 0.3 $29M 420k 68.16
Verrica Pharmaceuticals Common (VRCA) 0.3 $24M 4.0M 5.92
Kyverna Therapeutics Common (KYTX) 0.1 $12M 475k 24.84
Aadi Biosciences Common (AADI) 0.1 $6.7M 2.8M 2.34
Adverum Biotechnologies Common (ADVM) 0.1 $5.9M 417k 14.14